Report Precision Cancer Medicine

About Precision Cancer Medicine

“Precision cancer medicine,” in which treatment is tailored to each individual according to cancer characteristics such as genetic mutations, is expected to play an important role in the future.

However, “Precision cancer medicine” is currently limited in the number of medical indications, (a) the number of medical indications for its use is still quite limited; (b) it involves the use of genetic information; and (c) the costs of testing and treatment are often expensive. Due to these characteristics, various issues have arisen in developing personalized cancer care throughout Japan without bias.

HGPI launched the “Project for Considering the Future of Precision Medicine with Industry, Government, Academia, and Civil Society” in the summer of 2021, and generates policy advocacy for future cancer control.

[Research Report] A Nationwide Survey on Cancer in Japan: 20 Years Since the Enactment of the Cancer Control Act (April 28, 2026)
2026-04-28

[Research Report] A Nationwide Survey on Cancer in Japan: 20 Years Since the Enactment o ...>>

[Discussion Points] Policy Dialogue “Considering Comprehensive Genomic Profiling from the Perspective of Patient Access: Utilizing the Medical Service Fee Reimbursement System and the Mixed Medical Services Program to Meet the Needs of Today” (November 28, 2025)
2025-12-16

[Discussion Points] Policy Dialogue “Considering Comprehensive Genomic Profiling from th ...>>

[Public Comment Submission] Cancer Project “Basic Plan for Genomic Medicine Policies (Draft)” (August 1, 2025)
2025-08-20

[Public Comment Submission] Cancer Project “Basic Plan for Genomic Medicine Policies (Dr ...>>

[Event Report] Invitation-Only Policy Dialogue Event “Considering Comprehensive Genomic Profiling from the Perspective of Patient Access: Utilizing the Medical Service Fee Reimbursement System and the Mixed Medical Services Program to Meet the Needs of Today” (July 14, 2025)
2025-07-29

[Event Report] Invitation-Only Policy Dialogue Event “Considering Comprehensive Genomic ...>>

[Policy Recommendation] Ensuring Equitable Access to Cancer Gene Panel Testing and Key Considerations for Applying the Mixed Medical Services Program (April 28, 2025)
2025-07-14

[Policy Recommendation] Ensuring Equitable Access to Cancer Gene Panel Testing and Key C ...>>

[Event Report] Civil Society Statement Announced through WHO Collaboration in Preparation for the United Nations High-Level Meeting on NCDs (May 2, 2025)
2025-05-20

[Event Report] Civil Society Statement Announced through WHO Collaboration in Preparatio ...>>

[Event Report] Global Expert Meeting “Innovation in Cancer Care in Developing Countries ~City Cancer Challenge Initiatives“ (June 20, 2024)
2024-06-26

[Event Report] Global Expert Meeting “Innovation in Cancer Care in Developing Countries ...>>

[Announcement] HGPI Endorsed “Urgent Joint Statement on the Treatment of Comprehensive Genomic Profiling Test in the Revision of Medical Service Fee in FY2024” (June 19, 2024)
2024-06-19

[Announcement] HGPI Endorsed “Urgent Joint Statement on the Treatment of Comprehensive G ...>>

[Event Report] The Project for Considering the Future of Precision Medicine with Industry, Government, Academia, and Civil Society – The Global Expert Meeting: Toward Equitable Patient Access to Genomic Cancer Medicine (April 4, 2024)
2024-04-19

[Event Report] The Project for Considering the Future of Precision Medicine with Industr ...>>

[Announcement] HGPI Endorsed “Joint Statement on the Implementation of Comprehensive Genomic Profiling test” (December 15, 2023)
2023-12-21

[Announcement] HGPI Endorsed “Joint Statement on the Implementation of Comprehensive Gen ...>>

[Event Report] Non-partisan Diet Member study session: “Challenges and Prospects for Improving Patient Access to Genomic Cancer Medicine” (December 12, 2023)
2023-12-18

[Event Report] Non-partisan Diet Member study session: “Challenges and Prospects for Imp ...>>

[Event Report] The Project for Considering the Future of Precision Medicine with Industry, Government, Academia, and Civil Society – The Policy Dialogue Event “Challenges and Prospects for the Improving Patient Access to Genomic Cancer Medicine” (October 11, 2023)
2023-11-06

[Event Report] The Project for Considering the Future of Precision Medicine with Industr ...>>

PageTop